金河生物(002688.SZ):拟与关联方等设控股子公司 以实施盐酸多西环素项目
格隆汇 3 月 2日丨金河生物(002688.SZ)公布,公司拟与呼和浩特金益源管理咨询企业(有限合伙)(“金益源”),内蒙古金河控股有限公司(“金河控股”),自然人刘云龙、张鸿毅、苏保仲等人共同投资5000万元设立子公司内蒙古金河制药科技有限公司(暂定名,最终以工商注册登记为准,“金河制药公司”),并由该控股子公司负责实施“盐酸多西环素项目”。“盐酸多西环素项目”预计总投资9091.86万元。
新设公司金河制药公司注册资本5000万元,公司以自有资金现金方式出资2550万元持有51%的股权,金益源以自有资金现金方式出资650万元持有13%的股权,金河控股以自有资金现金方式出资300万元持有6%的股权,自然人刘云龙、张鸿毅、苏保仲等人以自有资金现金方式合计出资1500万元持有30%的股权。
金河控股为公司董事长王东晓和其配偶路牡丹投资设立的公司,公司董事长王东晓为金河控股执行董事,金河控股与公司构成关联关系。
公司副董事长李福忠担任金益源执行事务合伙人,副董事长张兴明、邬瑞岗,董事、总经理谢昌贤,财务总监牛有山,董事、副总经理王志军,副总经理云喜报、刘迎春、菅明生,控股股东内蒙古金河建筑安装有限责任公司(“金河建安”)总经理焦秉柱为金益源的有限合伙人之一,金益源与公司构成关联关系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.